Clinical trial

Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and…

NCT00191464 · Eli Lilly and Company, Industry · Completed

Key facts

NCT number NCT00191464
Title Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes
Official title Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes: A Comparison of Premeal Insulin Lispro Mixtures to Once-Daily Insulin Glargine
Lead sponsor Eli Lilly and Company, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Diabetes Mellitus, Type 2
Intervention type Drug
Interventions premeal insulin lispro mixtures, insulin glargine, metformin
Enrollment 320
Start date Dec 1, 2003
Completion Sep 1, 2005
First posted Sep 19, 2005
Last update posted Oct 13, 2010
Countries Australia, Greece, India, Netherlands, Poland, Puerto Rico, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies